ClinicalTrials.gg
RecruitingNCT06824493Updated Aug 12, 2026

Orthodontic Treatment on Oral Microbiota and Salivary Proteins

An observational study in Orthodontics, White Spot Lesions [Initial Caries] on Smooth Surface of Tooth and Caries, Dental, sponsored by Xi'an Jiaotong University. Recruiting at 1 site in China. Open to participants aged 6 Years to 18 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-08-12.

Sponsored by Xi'an Jiaotong University · Observational

From the registry’s dates

  • Started Jul 2025; still recruiting 1 year 4 months later.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
150
Ages
6 Years to 18 Years
Sex
All
01

Study summary

Study on the changes in oral microbiota during orthodontic treatment in patients aged 8-18 years. Orthodontic patients treated at Stomatology Hospital of Xi'an Jiaotong University from March 2025 to March 2027 will be recruited. Prior to orthodontic treatment, routine preoperative examinations will be conducted, informed consent forms will be signed, baseline oral conditions will be recorded, and oral and psychological-related questionnaires will be completed. Patients will be informed of the need for regular oral hygiene check-ups, caries risk assessments will be performed, and plaque, saliva, and intraoral photographs will be collected. During orthodontic treatment, plaque samples will be collected every 3 months, and saliva samples will be collected every 6 months until the treatment is completed to evaluate the changes in oral microbiota throughout the orthodontic process.

02

Conditions studied

  • Orthodontics
  • White Spot Lesions [Initial Caries] on Smooth Surface of Tooth
  • Caries, Dental

Browse trials for

Keywords

  • microbiota
03

In context

Dental Caries

1,171 studies on the registry are indexed under Dental Caries; 209 are open to participants now.

This study's planned enrollment of 150 is below the median of 174 across 187 observational studies indexed under Dental Caries.

Browse Dental Caries studies →

Lead sponsor

Xi'an Jiaotong University is the lead sponsor of 32 studies on the registry; 8 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
6 Years to 18 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

A description of the population from the population undergoing oral health examinations in primary schools

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • No carries and White spot
  • No missing teeth
  • No history of oral treatment
  • No malocclusion
  • No systemic diseases

Exclusion criteria

Exclusion Criteria:

  • Antibiotic use in the past three months
  • A history of long-term medication use
  • A history of dental fillings
  • Unable to attend regular follow-ups
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
150 participants (estimated)
Target follow-up
2 Years
Patient registry
Yes

Groups and cohorts

  • ID number

    Other: no interventions · Other: None-placebo · Other: No Intervention: Observational Cohort

Interventions

  • Otherno interventions

    no intervention as this is an observational studies

  • OtherNone-placebo

    Observational study with no interventions

  • OtherNo Intervention: Observational Cohort

    no intervention because of observational studies

06

What researchers measure

Primary outcomes

  1. Microbiota changes of plaque

    Samples of supragingival plaques will proceed to 16S rRNA sequencing for analysis of microbiome profiles, and q-PCR for evaluating bacterial loads of some critical pathogens for dental caries

    Time frame: baseline, collect plaque in the first month, then at Month 3, 6, 9, 12, 15, 18, 21, 24, 27,30 through study completion, an average of 30 months.

  2. Microbiota changes of saliva

    Samples of saliva will proceed to 16S rRNA sequencing for analysis of microbiome profiles, and q-PCR for evaluating bacterial loads of some critical pathogens for dental caries

    Time frame: Baseline, collect saliva at Months 6, 12, 18, 24, 30 through study completion, an average of 30 months.

  3. Monitoring dental lesion progression

    ICDAS(International Caries Detection and Assessment System) scoring system helps in detecting early caries, monitoring lesion progression, and developing tailored treatment strategies. Scoring Criteria: 0: No visible caries; 1: First visual change (only visible when dry); 2: Distinct visual change (visible without drying); 3: Initial enamel breakdown;4: Underlying dark shadow from dentin;5: Moderate cavity with dentin exposure; 6: Extensive cavity with pulp involvement

    Time frame: Baseline, follow-up assessments are conducted at Months 6, 12, 18, 24, 30 through study completion, an average of 30 months.

07

Study locations

1 of 1 sites recruiting
  • tomatology Hospital of Xi'an Jiaotong University,
    Xi'an, Shaanxi, China
    Recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jul 2025 (actual). Primary completion is estimated for Mar 2027, 20 months after the start.

Of 46 non-industry observational studies under Dental Caries, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 32. This study's planned 20 months is above that.

Counting every sponsor, half of 47 studies reached it within 12 months; a quarter within 7 and three quarters within 32.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 11, 2025
First posted
Feb 13, 2025
StartActual
Jul 1, 2025
Primary completionEst.
Mar 1, 2027
CompletionEst.
Sep 1, 2027
Last update
Aug 12, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 12, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT06824493
Lead sponsor
Xi'an Jiaotong University
Responsible party
Shanshan-Dai (attending physician of pediatric dentist and PhD in Orthodontics, Xi'an Jiaotong University) — Principal investigator
First posted
Feb 13, 2025
Start date
Jul 1, 2025
Primary completion
Mar 1, 2027 (estimated)
Completion
Sep 1, 2027 (estimated)
Last update
Aug 12, 2026

Study contacts

Shanshan Dai
Contact
daishanshan0723@163.com
86+15319976663
Yucheng Guo
Contact
xjtu-guoyucheng@163.com
86+15929935365

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion